Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.

Clinical trial NCT00737789 · COMPLETED

Trial details

NCT number: NCT00737789
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2008-11-01
Primary completion: 2010-06-01
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.